No Detail Found!

To Evaluate the Efficiency with which Patients who have had ND-YAG Laser Capsulotomy may Reduce their Intraocular Pressure with a Predetermined Dosage of Brimonidine/Tart-Rate [0.2%] and Timalol/Maleate [0.5%]

Author(s)
IMRAN AHMAD Department of Ophthalmology, Khyber Medical College, Khyber Teaching Hospital, Peshawar, Pakistan
JEHANZEB KHAN Department of Opthamology, Gajju Khan Medical College, Bacha Khan Medical Complex Swabi, Pakistan
MUHAMMAD ZEESHAN TAHIR Gajju Khan Medical College, Bacha Khan Medical Complex, Swabi, Pakistan
MUBASHIR REHMAN Department of Opthamology, Nowshehra Medical College, Nowshehra, Pakistan
Abstract
Background: The most prevalent type of glaucoma, known as primary open-angle glaucoma (POAG), is a major contributor to preventable blindness worldwide. Treating hypertensive ocular diseases, such as elevated intraocular pressure (IOP), may decrease the development and progression of (POAG). Objective: this study was to evaluate the efficiency with which patients who have had Nd-Yag laser capsulotomy may reduce their intraocular pressure with a predetermined dosage of brimonidine tartrate 0.2% and timalol maleate 0.5% Method: From January 2022 to January 2023, a prospective, randomized trial was conducted in the Department of Ophthalmology at KMC and KTH Peshawar. Sample size 100 patients who had undergone (Nd-Yag-laser capsulotomy) were enrolled in the study. After random selection, 50 patients were divided into two groups. Group 1 received (timolol maleate) [0.5%] BID daily and Group 2 received [0.5%] (timolol maleate) in a constant proportion in addition to (0.2%) brimonidine tartrate BID daily. Intraocular pressure (IOP) was assessed at the beginning, after one week, three weeks, and four weeks. The mean IOP at 4 weeks served as the major outcome indicator. Mean IOP at 1 week, 3 week, and 4 week intervals were included as secondary end measures. Descriptive statistics, the Student's t-test, and one-way ANOVA were used to analyse the data. Results: Mean IOP at baseline not significant with in two groups [P=0.36]. At one week, the mean IOP in the timolol group was 15.3 3.3 mmHg, compared to 13.1 2.9 mmHg in the timolol/brimonidine (P=0.001). At 3 weeks, (mean IOP) in the (timololgroup) was 14.4 3.1 mmHg, compared to 12.5 2.8 mmHg in the timolol/brimonidine group (p 0.001). At 4 weeks, the mean IOP in the timolol group was 13.8 3.1 mmHg, compared to 11.7 2.7 mmHg in the timolol/brimonidine group (p 0.001). Conclusion: this study show that persons who have had Nd-Yag laser capsulotomy benefit from a blending together timolol maleate [0.5%] and brimonidine tartrate [0.2%] to significantly reduce intraocular pressure (IOP).
Publication Details
Page(s) 504-505
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 17, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Intraocular Pressure, ttimolol- maleate, brimoni-dine- tartrate, Nd-Yag Laser-Capsulotomy
0

Citations

0

Downloads

79

Views